Literature DB >> 12027583

The role of cytokines in the epithelial cancer microenvironment.

Julia Wilson1, Fran Balkwill.   

Abstract

The epithelial tumour microenvironment is a complex tissue comprising variable numbers of tumour cells, fibroblasts, endothelial cells and infiltrating leucocytes. Cytokines are key molecules controlling autocrine or paracrine communications within and between these individual cell types. Under some circumstances, endogenous cytokines may orchestrate host responses against the tumour, but there is increasing evidence that the cytokine network contributes to tumour growth, progression and host immuno-suppression. In this review we outline some of the actions of endogenous cytokines in epithelial tumours with particular emphasis on tumour necrosis factor alpha, TNF, related inflammatory cytokines and the chemokine group of chemoattractant cytokines. Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027583     DOI: 10.1006/scbi.2001.0419

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  42 in total

1.  An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas.

Authors:  Xueyan Zhao; Travis Laver; Suk W Hong; George B Twitty; Annelies Devos; Marijke Devos; Etty N Benveniste; Susan E Nozell
Journal:  J Neurooncol       Date:  2011-01-30       Impact factor: 4.130

Review 2.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

3.  The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels.

Authors:  Yosra Bouraoui Mechergui; Awatef Ben Jemaa; Chekib Mezigh; Benito Fraile; Nawfel Ben Rais; Ricardo Paniagua; Mar Royuela; Ridha Oueslati
Journal:  Inflammation       Date:  2009-04-28       Impact factor: 4.092

4.  The Influence of Biomaterials on Cytokine Production in 3D Cultures.

Authors:  Mary C Regier; Sara I Montanez-Sauri; Michael P Schwartz; William L Murphy; David J Beebe; Kyung Eun Sung
Journal:  Biomacromolecules       Date:  2017-02-16       Impact factor: 6.988

5.  Increased presence of effector lymphocytes during Helicobacter hepaticus-induced colitis.

Authors:  Sarah J McCaskey; Elizabeth A Rondini; Jonathan F Clinthorne; Ingeborg M Langohr; Elizabeth M Gardner; Jenifer I Fenton
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

6.  Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.

Authors:  Chi-Chen Hong; Song Yao; Susan E McCann; Ree Y Dolnick; Paul K Wallace; Zhihong Gong; Lei Quan; Kelvin P Lee; Sharon S Evans; Elizabeth A Repasky; Stephen B Edge; Christine B Ambrosone
Journal:  Breast Cancer Res Treat       Date:  2013-04-30       Impact factor: 4.872

7.  Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.

Authors:  Fatemeh Mosaffa; Fatemeh Kalalinia; Herman Lage; Jalil Tavakol Afshari; Javad Behravan
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

Review 8.  Fatigue and sleep during cancer and chemotherapy: translational rodent models.

Authors:  Maria Ray; Laura Q Rogers; Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

9.  Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.

Authors:  Chung-Pin Li; Tze-Sing Huang; Yee Chao; Full-Young Chang; Jacquline Whang-Peng; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

10.  The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.

Authors:  Q Zhou; R L Geahlen
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.